IL-6, and tumor necrosis factor alpha (TNF-a) were measured in critically ill patients with pneumonia (ICUP; n=12) and less severely ill patients with pneumonia (NONICUP; n=8), and in 2 additional control groups of patients, viz, severely ill postoperative patients without evidence of infection (POSTOP; n=11) and less severely ill patients with nonpneumonia infections (NONP; n=9). All four groups of patients were studied in a multivariate one-way analysis of variance using the parameter vector: plasma IL-1fl, IL-6, TNF-a, systolic blood pressure, diastolic blood pressure, plasma urea, creatinine, and temperature. Thereafter the significance of individual parameters were assessed by univariate analysis and pairwise comparisons. Results: All cytokine concentrations were highest in the ICUP group. In the case of IL-Ifl, levels were significantly higher in the ICUP group when compared with the noninfected POSTOP group. The acute physiology and chronic health evaluation (APACHE) II scores were identical in these two groups (17 ± 3 [SD] and 10 ± 1, repneumonia is an ongoing cause of morbidity and mortality among patients worldwide, despite the availability of potent antimicrobial agents and the advanced technology used in many ICU facilities. 14 The mortality is particularly high among critically ill patients,2-4 and not all factors associated with the ongoing mortality have been fully elucidated. It is recognized, however, that there are a number of clinical and laboratory parameters which when present in patients with pneumonia on admission to the hospital are associated with a poorer prognosis.2 '3 More recently, it has become apparent that aspects of the host response to infection may be contributing to tissue injury. One component of the host response to infection is the release of monocyte and macrophage-derived cytokines, including interleukin (IL)-13, IL-6, and tumor necrosis factor alpha (TNF-a).5-8
The role of the cytokines in the septic syndrome is under intense scrutiny both experimentally9 '10 and in humans. ' The aim of the present study was to determine the pattern of cytokine expression in patients with pneumonia. We compared plasma cytokine concentrations of such patients requiring admission to an ICU with less severely ill patients. In particular, we wished to determine whether specific profiles of IL-1, IL-6, and TNF were predictors of severity of pneumonia. This was not simply to create a new severity of illness scoring index for pneumonia patients but because modern approaches to decreasing mortality in patients with various infections have focused on the manipulation of cytokines in such patients. It would seem that a rational approach would be to define accurately patterns of cytokines in specific disease states before such studies.
PATIENTS AND METHODS
This study was undertaken at the Hillbrow Hospital in Johannesburg and approved by the Committee for Research on Human Subjects of the University of the Witwatersrand.
We specifically studied patients with acute community-acquired pneumonia, defined as an acute respiratory tract infection in a previously healthy individual, associated with clinical and radiologic evidence of uni-or multi-lobar pulmonary consolidation. Two groups of patients with pneumonia were studied: a group of patients with severe disease requiring admission to an ICU (ICUP [n=12]), and a group of patients who were less severely ill and managed in the general medical wards (NONI-CUP [n=8]). In addition, two control groups were added to help define the pattern of cytokine responses. These were a group of patients with non-pneumonia infections not requiring admission to an ICU (NONP [n=9]), and a group of noninfected surgical patients ill enough to require ICU admission usually for mechanical ventilation (POSTOP [n= 11]). Severity of illness was assessed using the acute physiology and chronic health evaluation (APACHE) II index21 in the two pneumonia groups and in the surgical patients but could not be calculated in the non-pneumonia group because not all tests required for calculating the index were routinely performed.
The data recorded in each group of patients included the demographic details, clinical features of illness, microbiology results, laboratory tests performed, and the outcome. For the measurement of the plasma cytokine levels, a single sample of heparinized venous blood samples was taken from consecutive patients within each of the groups on admission to the general wards or ICU and specifically before any therapy was instituted. These specimens were centrifuged and the plasma collected, avoiding contamination with the buffy coats. The plasma was stored at -700C, and the assays were performed in a single batch by one of the authors (A.P.) who was blinded to the clinical details of individual patients. The assays used were radioimmunoassays for IL-1f (Amersham), IL-6 (Amersham), and TNF-ar (Medgenix). Before testing for IL-1/3, the cytokine was extracted using 0.5 mL plasma and 1 mL of chloroform as previously recommended. 22 To determine the significance of the plasma concentrations of cytokines obtained in the various patient groups, the concentrations were determined in the plasma of ten normal Tables 1 to 3 . No single organism predominated in the ICUP group, and blood cultures were negative in 50% of cases. In the NONICUP group, all had negative blood cultures. In five patients, Gram-positive diplococci thought to be Streptococcus pneumoniae were detected on sputum Gram's stain, but subsequent cultures were negative. Escherichia coli was the predominant organism isolated from urine or blood culture in the NONP group (56%).
The plasma concentrations of the individual cytokines are shown in Tables 5 and 6. Table 5 shows the initial comparison of cytokine levels between the ICUP and NONICUP groups. The plasma concentrations for IL-1: and IL-6 were not significantly different, although the values for TNF-a were sig- nificantly higher in the ICUP group of patients in comparison with the NONICUP patients (61 ± 17.5 vs 9.5 ± 1.5 pg/mL, respectively; p=0.029).
With respect to the parameter vector, multivariate analysis using all four patient groups showed significant differences between these groups (p=0.003), in particular with respect to levels of IL-1: (p=0.016), TNF-a (p=0.017), urea (p=0.014), and creatinine (p=0.0002). Differences in IL-6 concentrations did not reach statistical significance between the groups at the 5% level (p=0.056). Significant differences in cytokine concentrations in the case of IL-1: were between the ICUP and POSTOP groups (Table 6; p<0.05), and in the case of TNF-a between the ICUP and NONICUP groups (Table 6 ; p<0.05). The IL-13, IL-6, and TNF-a plasma concentrations were significantly different in the ICUP vs the normal control group at the following levels of significance, respectively: p<0.001, p<0.05, and p<0.01. With regard to IL-1: concentrations, the highest concentrations were found in the ICUP group (659 ± 67.5 pg/mL) and the lowest levels in the POSTOP group (443 ± 18.5 pg/ Table 6 . There were no significant differences in the IL-6 concentrations between the groups on multivariate analysis. In particular, there was no significant difference between the ICUP and POSTOP groups, the two groups with the highest APACHE II scores, which were found to have the highest values of IL-6 among all the groups (1,773 + 447.7 and 1,676 ± 502.8 pg/mL, respectively; Table 6 ). The TNF-a concentrations tended to mimic those of the IL-1: group. However, while the highest concentration was found in the ICUP group (61 ± 17.5 pg/mL), the lowest level was in the NONICUP group (9.5 ± 1.5 pg/mL), this difference being significant (Table 6 ; p<0.05). The urea concentration was found to be significantly higher in the ICUP group than the POSTOP group (p<0.05). Creatinine concentrations were confirmed to be significantly higher in the ICUP group when compared with any of the other groups of patients, vs NON-ICUP-p<0.01, and vs NONP and POSTOP-p< 0.001, respectively.
The only association between the individual cytokines and parameters of fever, systolic and diastolic pressure, urea and creatinine levels was between IL-1: and temperature (r=0.4, p<0.05). There was a significant association between plasma IL-6 and TNF-a concentrations and between IL-1: and TNF-a (p<0.05 in both cases) for both pneumonia groups and for all groups (p<0.05 and p<0.005, respectively) as determined by the linear regression equation and correlation coefficient. However, the correlation was poor as reflected by the very low coefficients of determination. There was a significant association between the APACHE II scores of all patients and the individual cytokines. The weakest association was with IL-1f (r=0.392; p<0.03) and the strongest association was with IL-6 (r=0.554; p<0.0012) and TNF-a (r=0.626; p<0.0002; Fig 1) .
Five patients in the ICUP group died. However, there was no association noted between the individual cytokine levels and patient mortality, irrespective of how the data were analyzed. The present study determined the cytokine profile of patients with acute community-acquired pneumonia, ICUP with NONICUP. The primary aim was to determine the specific pattern of cytokines in the ICUP group. Such knowledge may lead to rational approaches to the manipulation of cytokine levels in severely ill patients with pneumonia in an attempt to decrease the ongoing high mortality in such cases. A single measurement of the plasma cytokines admission to the hospital, before therapy, was chosen to determine the cytokine profile. Although this represents a measurement at only one point, it is acknowledged that there is chronicity of expression of cytokines in patients, which differs from the estab- lished experimental models where there is the rapid appearance and disappearance of the cytokines.23
The duration of illness, where this could be determined, varied and this factor could influence cytokine patterns. Limited evidence indicates that the expression of at least TNF-a is stable over time in patients with sepsis. 23 The APACHE II score was significantly higher in the ICUP vs the NONICUP group (p=0.002), in keeping with their more severe illness. In addition, a number of other parameters, which previously have been described as negative prognostic factors or factors predicting the need for ICU admission in patients with pneumonia,2'3 were noted to be significantly different between the two groups. These included a higher age, greater tachycardia, lower WBC and platelet counts, higher serum urea and creatinine values, and a lower serum albumin level in the more seriously ill patients. Although IL-1: and IL-6 levels were not significantly different between these two groups; TNF-a levels were significantly higher in the ICUP cases. Multivariate analysis allowed better definition of the possible associations of these cytokine levels in patients with pneumonia.
The IL-1: detection in plasma/serum under conditions of experimental endotoxemia and sepsis is controversial.9 '24-26 In several studies, it has not been possible to detect significant concentrations of IL-1.10'24 Other studies have found elevated concentrations of IL-1: in patients who survived septic shock,25 which may suggest a protective role for IL-l1:. In the present study, we were able to measure elevated IL-1: concentrations in the plasma of our patients. The highest concentrations of IL-1: were found in the ICUP group, and significantly lower levels in the non-septic POSTOP patients (p<0.05). The two groups of patients with intermediate levels of infection had intermediate levels of this cytokine. Our results suggest that IL-1: concentrations appear to be related to the severity of infection of patients on admission.
The has been identified as an important mediator of the synthesis of the acute phase reactants and this cytokine also has a possible role in the mediation of IL-1: and TNF actions.14'16'27 An alternative view is that IL-6 is a counter-regulatory/antiinflammatory cytokine of the proinflammatory cytokines IL-1: and TNF-a. For example, IL-6 is known to downregulate the synthesis of monocyte-produced cytokines.12 Several studies have reported the detection of IL-6 in the plasma of patients under conditions of sepsis.16 '28 In some cases, IL-6 concentrations have appeared to be related to the outcome in patients with sepsis,16'29 although this has not always been confirmed.29 In the present study, multivariate analysis failed to confirm any significant differences in the IL-6 concentrations among the four groups. In contrast to the IL-1: results, the levels of IL-6 were highest, and almost equal, in the ICUP and noninfected POSTOP groups, the groups with the highest APACHE II scores. The analyses suggest that IL-6 may be more closely associated with the severity of illness and that raised plasma levels may more accurately relate to severity of stress, whether of an infective or noninfective nature rather than severity of infection per se.
The TNF-a has been identified as an important mediator of septic shock in both experimental models and in patients.6,10,24,25,30-33 The effects of TNF-a in septic shock are thought to be mediated through the action of TNF-a on endothelial cells, the myocardium, and through paracrine and autocrine loops.34 '35 Studies have suggested that there may be synergy between TNF-a and IL-1: in the induction of shock.17 In some reports, the concentrations of TNF-a have been found to be related to the degree of sepsis.25 '29'31 In our study, the levels of TNF-a, like that of the other cytokines, were highest in the ICUP group. The pattern of TNF-a expression among the groups was similar to that found with IL-13, the only difference being that TNF-a concentrations were significantly lower in the NONICUP group. It is tempting to suggest, therefore, that differences in TNF-a levels in our study reflect differences in the severity of pneumonia in our patients. However, it should be borne in mind that there were a number of significant differences noted between the ICUP and NONICUP groups as shown in Table 1 , which in themselves may have accounted for differences noted in the TNF-a levels.
An additional finding from the multivariate analysis was the significantly higher concentration of urea in the ICUP group compared with the POSTOP group and of creatinine in the ICUP group compared with any of the other groups. This almost certainly reflects the importance of renal dysfunction as an indicator of poorer prognosis or need for ICU admission in patients with pneumonia, factors that have been regularly described before.1-3 Using the correlation coefficient, we found that the only association between the individual cytokines and the various clinical and laboratory features was with IL-1: and temperature (p<0.05).
Our study suggests that measurement of plasma levels of cytokines IL-1:, IL-6, and TNF in patients with pneumonia may reflect various clinical scenarios; IL-1: may reflect severity of infection; IL-6, severity of illness (whether of an infective or noninfective nature); and TNF-ax concentrations, the severity of pneumonia. A weak correlation was found between the concentrations of IL-1: and TNF-a, which does not necessarily exclude the possibility of additive or synergistic interactions between the two cytokines as previously described.17 Although the individual data are not shown, we were unable to show any association between cytokine concentrations and outcome. This is almost certainly due to the relatively small number of patients studied. In addition, although TNF-a appeared to correlate with the severity of pneumonia, it did not correlate with outcome. Previous studies showing a correlation of TNF-a with outcome were in cases with serum concentrations greater than 140 pg/mL,32 concentrations much higher than reported in the present study. The APACHE II scores of all patients studied were associated with the concentrations of the individual cytokines; the strongest association was with TNF-a stressing the possible centrality of the cytokine under various conditions of stress. Our study and another recently reported study36 are one of the few that have attempted to profile cytokine expression in various clinical scenarios. The present results and those from the reported study36 emphasize that different cytokine patterns are possible despite the differences in clinical pathologic findings and insignificant differences in severity as assessed by the APACHE II scores. The reported study36 shows an association between IL-1:, IL-6, and TNF-a under conditions of infection in comparison to patients without infection but with equivalent APACHE II scores. By contrast, our control group (POSTOP) had indistinguishable plasma concentrations from the ICU pneumonia group but was distinct from the latter group when comparing IL-13 and TNF-a concentrations.
The current study, like that of others,29 does not allow the elucidation of whether greater elevations of cytokine levels occurred in some patients as a consequence of more severe illness or infection, or whether they actually contributed to the degree of illness. However, it is possible that in the future, measurement of absolute levels of cytokines may be of use in identifying more seriously ill patients, and cases likely to die, who could be singled out for more intensive therapy at an earlier phase of illness. In addition, manipulation of cytokine levels by reduction of cytokine production,12 or the use of agents inhibiting end-organ sites of action, such as the recently described IL-1,B receptor antagonist,' 12"937-39 may be found to have additional benefit in infections such as pneumonia, a disease that continues to have significant morbidity and mortality.
